|
MYD88 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.07989999953828E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55980000027256E-07 |
| Normal-vs-Stage2 |
5.136400E-01 |
| Normal-vs-Stage3 |
4.44010000000272E-05 |
| Normal-vs-Stage4 |
3.161900E-04 |
| Stage1-vs-Stage2 |
5.036400E-04 |
| Stage1-vs-Stage3 |
9.803600E-01 |
| Stage1-vs-Stage4 |
8.995400E-01 |
| Stage2-vs-Stage3 |
1.624210E-03 |
| Stage2-vs-Stage4 |
4.003500E-03 |
| Stage3-vs-Stage4 |
9.068400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.20759999777675E-08 |
| Normal-vs-AfricanAmerican |
2.712400E-02 |
| Normal-vs-Asian |
9.65950000000326E-05 |
| Caucasian-vs-AfricanAmerican |
2.333200E-01 |
| Caucasian-vs-Asian |
6.010600E-01 |
| AfricanAmerican-vs-Asian |
3.668600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.45829999999669E-05 |
| Normal-vs-Female |
1.01710000000033E-06 |
| Male-vs-Female |
8.403600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.43319999704283E-08 |
| Normal-vs-Age(41-60Yrs) |
7.89589999999896E-05 |
| Normal-vs-Age(61-80Yrs) |
6.916600E-03 |
| Normal-vs-Age(81-100Yrs) |
9.279700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.362100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.105560E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.404000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.016000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.422800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.786400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.436500E-02 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
9.432800E-01 |
| Classical-VS-Normal |
5.21020004917716E-10 |
| Tall-VS-Follicular |
1.61230000461643E-08 |
| Tall-VS-Other |
3.758800E-01 |
| Tall-VS-Normal |
1.03569999998498E-06 |
| Follicular-VS-Other |
6.192300E-02 |
| Follicular-VS-Normal |
7.690000E-02 |
| Other-VS-Normal |
1.325020E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.061980E-03 |
| Normal-vs-N1 |
7.998700E-04 |
| N0-vs-N1 |
2.100800E-01 |
|
|
